Bicocca Open Archive

Logo unimib boa
CAZZANIGA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.994
EU - Europa 8.186
AS - Asia 3.762
SA - Sud America 45
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 13
Totale 33.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.741
IT - Italia 1.691
CN - Cina 1.382
IE - Irlanda 1.377
SE - Svezia 1.267
SG - Singapore 1.258
DE - Germania 1.008
RU - Federazione Russa 904
UA - Ucraina 693
HK - Hong Kong 541
GB - Regno Unito 383
CA - Canada 249
FI - Finlandia 222
FR - Francia 174
VN - Vietnam 162
ID - Indonesia 148
AT - Austria 140
TR - Turchia 97
IN - India 88
DK - Danimarca 70
NL - Olanda 68
BE - Belgio 60
JP - Giappone 31
BR - Brasile 28
ES - Italia 21
BG - Bulgaria 16
CH - Svizzera 16
EU - Europa 16
IR - Iran 15
GR - Grecia 13
AU - Australia 12
CZ - Repubblica Ceca 11
NO - Norvegia 11
RO - Romania 11
AR - Argentina 10
EG - Egitto 8
KR - Corea 8
PL - Polonia 8
MU - Mauritius 6
PT - Portogallo 6
TH - Thailandia 6
CL - Cile 4
PH - Filippine 4
RE - Reunion 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IL - Israele 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MX - Messico 2
NG - Nigeria 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GL - Groenlandia 1
HU - Ungheria 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
TG - Togo 1
VE - Venezuela 1
Totale 33.046
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.634
Fairfield 2.292
Woodbridge 2.114
Houston 1.639
Dublin 1.345
Chandler 1.252
Ashburn 1.107
Singapore 1.091
Wilmington 1.058
Seattle 870
Cambridge 798
Jacksonville 755
Frankfurt am Main 752
Dearborn 605
Hong Kong 538
New York 536
Santa Clara 497
Princeton 492
Milan 434
Lawrence 239
Nanjing 227
Altamura 224
Shanghai 191
Beijing 157
Jakarta 147
San Diego 147
Vienna 137
Lachine 124
Helsinki 81
Dong Ket 80
Andover 79
Nanchang 77
Lissone 74
Toronto 69
Shenyang 63
Fuzhou 59
Guangzhou 59
Rome 58
Brussels 56
Hebei 55
Boardman 53
Changsha 48
Jinan 48
Tianjin 47
London 45
Norwalk 41
Los Angeles 39
Falls Church 34
Chicago 33
Jiaxing 32
Ningbo 29
Zhengzhou 29
Ottawa 28
Hangzhou 27
Kunming 26
Paris 26
Besana In Brianza 25
Fremont 25
Pune 25
Redmond 24
Kocaeli 23
Mountain View 23
Como 22
Dallas 20
Huizen 20
Monza 20
Bologna 19
Padova 19
Turin 19
Hefei 18
Göttingen 17
San Mateo 17
Munich 16
Cinisello Balsamo 15
Florence 14
Edmonton 13
Grafing 13
Sesto San Giovanni 13
Taizhou 13
Carate Brianza 12
Athens 11
Bergamo 11
Brugherio 11
Nürnberg 11
Washington 11
Hounslow 10
Lappeenranta 10
Naples 10
Perugia 10
Romola 10
Chengdu 9
Leawood 9
Mariano Comense 9
Oslo 9
Phoenix 9
Verona 9
Allentown 8
Auburn Hills 8
Bari 8
Moscow 8
Totale 25.433
Salva come PNG Salva come JPEG
Nome #
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 349
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 318
NIPBL: a new player in myeloid cells differentiation 311
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 304
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 289
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 288
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 277
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 271
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 267
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 247
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 245
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 244
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 241
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 240
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 233
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 222
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 219
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 217
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 216
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 210
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 208
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 207
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 201
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 197
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 197
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 197
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 195
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 194
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 194
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 194
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 193
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 191
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 191
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 191
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 190
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 187
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 185
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 184
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts 183
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 183
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 183
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 182
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 182
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 180
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 180
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia 178
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 176
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 175
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 173
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 172
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 172
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 169
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 169
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 168
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 167
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 166
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 166
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 165
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome 164
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study 164
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol 164
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 164
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis 163
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 163
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias 161
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study 161
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 161
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 161
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations 160
TEL/ARG induces cytoskeletal abnormalities in 293T cells 160
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 159
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 159
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 159
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 158
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 158
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 158
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 156
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia 156
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 155
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 155
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 154
Predictive factors of relapse and survival in childhood acute myeloid leukemia: Role of minimal residual disease 154
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 154
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells 154
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 153
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 153
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: Revisited in AIEOP-BFM protocol 152
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 151
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 149
Metabolic gatekeeper function of B-lymphoid transcription factors 148
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia 147
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 146
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 146
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 146
T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses 143
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 142
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 142
SSBP2-CSF1R is a Recurrent Fusion in B-lineage Acute Lymphoblastic Leukaemia with Diverse Genetic Presentation and Variable Outcome 142
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 139
Novel clinical trials for pediatric leukemias: lessons learned from genomic analyses 139
Totale 18.666
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.392 0 0 0 0 0 776 796 450 553 343 317 157
2020/20215.491 222 341 432 474 446 436 816 678 399 494 350 403
2021/20223.278 232 342 419 237 256 271 123 177 208 230 227 556
2022/20235.119 663 1.625 374 426 282 793 67 292 332 31 154 80
2023/20244.081 119 130 173 185 528 1.087 816 152 357 85 81 368
2024/20253.676 466 1.067 552 447 866 278 0 0 0 0 0 0
Totale 34.178